Identification of Changes in the Human Papilloma Virus 16 (HPV16) Genome During Early Dissemination of Cervical Cancer Cells May Complement Histological Diagnosis of Lymph Node Metastasis
Tóm tắt
Cancer of the uterine cervix (CACX) is one of the most common carcinoma affecting women worldwide. During treatment, histologically lymph node (LN) metastasis and presence of HPV DNA in blood plasma act as a major prognostic factor. Despite the lack of apparent LN involvement, some early-invasive CACX patients have shown recurrences and poor survival. This is suggestive of undetected early dissemination of cancer cells characterized by presence of HPV DNA in histologically non-metastatic LNs which finally progresses into histologically visible metastasis. This present study investigated the status and origin of HPV genome during early dissemination by molecular analysis in primary tumor (PT), histologically non-metastatic pelvic lymph nodes (LNs) and blood plasma (BP) of same patient. First, CACX patients showing signs of early dissemination was identified by detection of HPV in PT (n = 22) and their corresponding histologically non-metastatic pelvic LNs (n = 45) and BP (n = 18) followed by typing of HPV16/18. This was followed by comparative analysis of the physical, copy number and methylation (enhancer/early/late) status of HPV16 genome present in LNs and BP with that of PT. Our study revealed for the first time that the HPV16 genome were frequently present in the integrated form though the copy number was low in both non-metastatic LNs and BP. However, the methylation pattern of PT was discordant with that of corresponding LNs and BP in majority of the cases. Critical assessment of HPV16 profiles established that the presence of hrHPV may be due to the early dissemination of PT cells having significant pathological implications.
Tài liệu tham khảo
Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Bosch FX, Munoz N (2002) The viral etiology of cervical cancer. Virus Res 89(2):183–190
Walboomers JM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19
Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7(1):11–22
Wong SY, Hynes RO (2006) Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5(8):812–817
Noventa M et al (2014) Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review. Clin Exp Metastasis 31(7):853–867
Lancaster WD et al (1986) Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 154(1):115–119
Park Y et al (2011) Expected clinical applications of circulating tumor cells in breast cancer. World J Clin Oncol 2(8):303–310
Pornthanakasem W et al (2001) Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer 1:2
Singh RK et al (2006) Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 16(3):1048–1054
Dutta S et al (2016) Alteration of human papillomavirus type 16 genetic and epigenetic profiles in cervical cancer patients is indicative of poor disease prognosis: a cohort analysis. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 26(4):750–757
Steenbergen RD et al (2014) Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 14(6):395–405
Dutta S et al (2012) Prevalence of human papillomavirus in women without cervical cancer : a population-based study in Eastern India. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists 31(2):178–183
Dutta S et al (2015) Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation. J Clin Pathol 68(3):206–211
Mazumder Indra D et al (2011) Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecol Oncol 123(3):597–604
Chakrabarti S et al (2001) Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population. Int J Cancer 92(4):555–561
Sambrook J, Russell DW, Sambrook J (2006) The condensed protocols from molecular cloning : a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
Swan DC et al (1999) Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37(4):1030–1034
Shukla S et al (2014) Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian J Med Res 139(4):531–543